XML 18 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

The Company permits officers and directors to adopt written trading plans, known as “Rule 10b5-1 trading arrangements”, as such term defined in Item 408(a) of Regulation S-K for the purchase or sale of the Company's securities, which are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. During the three months ended March 31, 2024, our executive officers and directors adopted, modified or terminated Rule 10b5-1 trading arrangements for the purchase or sale of our common stock as noted below:

 

Name and Title of Director or Officer

Action

Date of Adoption

 

Duration of the Plan or Termination Date

 

Aggregate Number of Shares of Common Stock that may be Sold under the Plan

 

Jay Duker, MD,
President and Chief Executive Officer

Termination

June 6, 2023

 

January 17, 2024

 

 

146,498

 

Jay Duker, MD,
President and Chief Executive Officer

Adoption

February 7, 2024

 

February 7, 2025

 

 

128,344

 

Scott Jones,
Chief Commercial Officer

Termination

September 21, 2023

 

February 6, 2024

 

 

161,655

 

Dario Paggiarino,
Former Chief Medical Officer

Termination

June 22, 2023

 

February 5, 2024

 

 

204,357

 

Anthony Adamis,
Director

Adoption

February 12, 2024

 

February 12, 2025

 

 

57,766

 

David Guyer, MD,
Director

Adoption

January 25, 2024

 

January 31, 2025

 

 

104,864

 
Rule 10b5-1 Trading Plan One  
Trading Arrangements, by Individual  
Name Jay Duker
Title MD, President and Chief Executive Officer
Adoption Date June 6, 2023
Rule 10b5-1 Arrangement Terminated true
Termination Date January 17, 2024
Aggregate Available 146,498
Rule 10b5-1 Trading Plan Two  
Trading Arrangements, by Individual  
Name Jay Duker
Title MD, President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 7, 2024
Termination Date February 7, 2025
Aggregate Available 128,344
Rule 10B51 Trading Plan Three  
Trading Arrangements, by Individual  
Name Scott Jones
Title Chief Commercial Officer
Adoption Date September 21, 2023
Rule 10b5-1 Arrangement Terminated true
Termination Date February 6, 2024
Aggregate Available 161,655
Rule 10B51 Trading Plan Four  
Trading Arrangements, by Individual  
Name Dario Paggiarino
Title Former Chief Medical Officer
Adoption Date June 22, 2023
Rule 10b5-1 Arrangement Terminated true
Termination Date February 5, 2024
Aggregate Available 204,357
Rule 10B51 Trading Plan Five  
Trading Arrangements, by Individual  
Name Anthony Adamis
Title Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 12, 2024
Termination Date February 12, 2025
Aggregate Available 57,766
Rule 10b51 Trading Plan Six  
Trading Arrangements, by Individual  
Name David Guyer
Title MD,Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date January 25, 2024
Termination Date January 31, 2025
Aggregate Available 104,864